Literature DB >> 9073510

Structural organization of the human prostaglandin EP3 receptor subtype gene (PTGER3).

M Kotani1, I Tanaka, Y Ogawa, T Usui, N Tamura, K Mori, S Narumiya, T Yoshimi, K Nakao.   

Abstract

Prostaglandin EP3 receptor subtype is a seven-membrane-spanning protein with multiple C-terminal tails generated by alternative mRNA splicing. We report here the structural organization of the human EP3 gene (PTGER3). The human EP3 gene spanned more than 80 kb and was composed of 10 exons separated by nine introns. Exon 1 and the 5' 180-bp portion of exon 2 (exon 2a) encoded the seven transmembrane domains and 10 amino acid residues of the cytoplasmic tail, which are common to all EP3 isoforms. The 3' 3461-bp portion of exon 2 (exon 2b) or combinations of exons 3-10 encoded the EP3 isoform-specific C termini and formed their 3'-untranslated regions by multiple fashions of alternative mRNA splicing. Exons 2b, 4, 6, and 10 contained polyadenylation sites. The EP3 gene formed nine distinct mRNAs encoding eight EP3 isoforms, two of which were novel ones tentatively designated EP3-V and EP3-VI. The transcription initiation sites of the human EP3 gene were mapped 227 to approximately 231 bp upstream of the ATG start codon. The 360-bp 5'-flanking region contained a TATA box-like sequence, a GC box, and several cis-acting regulatory elements. The present study provides insight into the molecular mechanisms underlying the prostanoid receptor family.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9073510     DOI: 10.1006/geno.1996.4585

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  27 in total

1.  PGE(2) is a UVR-inducible autocrine factor for human melanocytes that stimulates tyrosinase activation.

Authors:  Renny J Starner; Lindy McClelland; Zalfa Abdel-Malek; Alex Fricke; Glynis Scott
Journal:  Exp Dermatol       Date:  2010-05-25       Impact factor: 3.960

Review 2.  MicroRNA and AU-rich element regulation of prostaglandin synthesis.

Authors:  Ashleigh E Moore; Lisa E Young; Dan A Dixon
Journal:  Cancer Metastasis Rev       Date:  2011-12       Impact factor: 9.264

3.  Downregulation of lipopolysaccharide-induced intercellular adhesion molecule-1 expression via EP2/EP4 receptors by prostaglandin E2 in human fibroblasts.

Authors:  K Noguchi; K Iwasaki; M Shitashige; M Umeda; Y Izumi; S Murota; I Ishikawa
Journal:  Inflammation       Date:  2001-04       Impact factor: 4.092

Review 4.  A Review of Prostanoid Receptors: Expression, Characterization, Regulation, and Mechanism of Action.

Authors:  Roger G Biringer
Journal:  J Cell Commun Signal       Date:  2020-09-24       Impact factor: 5.782

5.  Prostanoid EP₁ receptors mediate up-regulation of the orphan nuclear receptor Nurr1 by cAMP-independent activation of protein kinase A, CREB and NF-κB.

Authors:  R Ji; C M Sanchez; C L Chou; X B Chen; D F Woodward; J W Regan
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

6.  Characterization of the gene for the mouse prostaglandin E receptor subtype EP2: tissue-specific initiation of transcription in the macrophage and the uterus.

Authors:  M Katsuyama; Y Sugimoto; K Okano; E Segi; R Ikegami; M Negishi; A Ichikawa
Journal:  Biochem J       Date:  1998-03-15       Impact factor: 3.857

7.  Downregulation of prostaglandin E receptor subtype EP3 during colon cancer development.

Authors:  Y Shoji; M Takahashi; T Kitamura; K Watanabe; T Kawamori; T Maruyama; Y Sugimoto; M Negishi; S Narumiya; T Sugimura; K Wakabayashi
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

8.  Intermolecular cross-talk between the prostaglandin E2 receptor (EP)3 of subtype and thromboxane A(2) receptor signalling in human erythroleukaemic cells.

Authors:  Helen M Reid; B Therese Kinsella
Journal:  Br J Pharmacol       Date:  2009-08-20       Impact factor: 8.739

9.  Reduced acute brain injury in PGE2 EP3 receptor-deficient mice after cerebral ischemia.

Authors:  Sofiyan Saleem; Yun Tai Kim; Takayuki Maruyama; Shuh Narumiya; Sylvain Doré
Journal:  J Neuroimmunol       Date:  2009-02-08       Impact factor: 3.478

10.  International Union of Basic and Clinical Pharmacology. CIX. Differences and Similarities between Human and Rodent Prostaglandin E2 Receptors (EP1-4) and Prostacyclin Receptor (IP): Specific Roles in Pathophysiologic Conditions.

Authors:  Xavier Norel; Yukihiko Sugimoto; Gulsev Ozen; Heba Abdelazeem; Yasmine Amgoud; Amel Bouhadoun; Wesam Bassiouni; Marie Goepp; Salma Mani; Hasanga D Manikpurage; Amira Senbel; Dan Longrois; Akos Heinemann; Chengcan Yao; Lucie H Clapp
Journal:  Pharmacol Rev       Date:  2020-10       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.